Clinical Trial Update: Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)

View source ↗

Summary

This is a completed post-marketing surveillance study evaluating the safety of Linaclotide tablets in patients with chronic constipation and irritable bowel syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Linaclotide (linaclotide)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Constipation (CC) (Excluding Constipation Due to Organic Diseases), Irritable Bowel Syndrome With Constipation (IBS-C) | Status: COMPLETED